The global Upstream Bioprocessing Market had a value of USD 9.79 billion in 2022. It is projected to reach USD 18.0 billion by 2032, with a forecasted revenue compound annual growth rate (CAGR) of 7%. This growth is primarily fueled by several key factors. One of the major drivers behind the increasing market revenue is the growing demand for biopharmaceuticals. These drugs are produced from...